This website is for the U.S, for the other countries please refer to this link.

Cardiac neuropathy

SUDOSCAN in cardiovascular autonomic neuropathy screening

Cardiac neuropathy, Diabetes, Scientific publications / By Impeto Medical

SUDOSCAN in cardiovascular autonomic neuropathy screening Yun-Ru Lai, Chih-Cheng Huang, Ben-Chung Cheng, Nai-Wen Tsai, Wen-Chan Chiu, Hsueh-Wen Chang, Jung-Fu Chen, Cheng-Hsien Lu. Article title: Feasibility of combining heart rate variability and electrochemical skin conductance as screening and severity evaluation of cardiovascular autonomic neuropathy in type 2 diabetes. Muscle Nerve. 2021 Apr 1 YR Lai et …

SUDOSCAN in cardiovascular autonomic neuropathy screening Read More »

Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

SUDOSCAN in cardiovascular autonomic neuropathy screening

ABOUT US:

MORE INFORMATION:

FOLLOW US ON:

CONTACT INFO: